Inventor · disambiguated record
Kenneth Katschke
Also filed as: KATSCHKE JR KENNETH · KATSCHKE JR KENNETH J · KATSCHKE JR KENNETH JAMES · KATSCHKE KENNETH
9 granted patents·7 pending applications·112 citations·filing 2004–2018
88Inventor score
Top patents by PatentIndex Score
16 records- 0193US8007798B2Treatment of complement-associated disordersGENENTECH INC·Filed 2005·Granted Aug 30, 2011·29 cites·47 claims
- 0292US8007791B2Prevention and treatment of complement-associated eye conditionsGENENTECH INC·Filed 2008·Granted Aug 30, 2011·26 cites·13 claims
- 0392US7419663B2Treatment of complement-associated disordersGENENTECH INC·Filed 2004·Granted Sep 2, 2008·33 cites·24 claims
- 0487US8268310B2Prevention and treatment of complement-associated eye conditionsHASS PHILIP·Filed 2011·Granted Sep 18, 2012·12 cites·7 claims
- 0583US9738727B2Anti-HtrA1 antibodies and methods of useGENENTECH INC·Filed 2012·Granted Aug 22, 2017·6 cites·33 claims
- 0678US8088386B2Treatment of complement-associated disordersASHKENAZI AVI·Filed 2005·Granted Jan 3, 2012·3 cites·6 claims
- 0774US8497094B2Prevention and treatment of complement-associated eye conditionsHASS PHILIP·Filed 2012·Granted Jul 30, 2013·2 cites·9 claims
- 0873US7930109B2Crystal structure of CRIg and C3b:CRIg complexGENENTECH INC·Filed 2009·Granted Apr 19, 2011·1 cites·15 claims
- 0960US2013302333A1Prevention and treatment of complement-associated eye conditionsGENENTECH INC·Filed 2013·Application pending·0 cites
- 1059US2018079826A1Prevention and treatment of complement-associated eye conditionsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1158US7776573B2Crystal structure of CRIg and C3b:CRIg complexGENENTECH INC·Filed 2007·Granted Aug 17, 2010·0 cites·4 claims
- 1255US2016272726A1Prevention and treatment of complement-associated eye conditionsGENENTECH INC·Filed 2016·Application pending·0 cites
- 1355US2019016826A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USEGENENTECH INC·Filed 2018·Application pending·0 cites
- 1452US2017342163A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USEGENENTECH INC·Filed 2017·Application pending·0 cites
- 1550US2012189626A1Treatment of complement-associated disordersASHKENAZI AVI·Filed 2011·Application pending·0 cites
- 1648US2017042967A1Treatment of complement-associated disordersGENENTECH INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →